This report provides a detailed overview of Type 2 Diabetes Mellitus and the role of Sulphonylurea in its management. It begins with an introduction to the disease, defining it as a chronic ailment characterized by insulin resistance and hyperglycemia, often linked to lifestyle factors. The report then delves into the pathophysiology of Type 2 Diabetes, exploring the dysfunction of the endocrine unit of the pancreas and the pathway of insulin secretion. It outlines the aetiology, highlighting risk factors like age, lifestyle, and dietary patterns. The pharmacology section focuses on Sulphonylurea drugs, explaining their mechanism of action in promoting insulin secretion, their pharmacokinetics, and potential side effects like hypoglycemia. The report also discusses the drug's contraindications and interactions. The conclusion summarizes the physiological and pathophysiological aspects of Type 2 Diabetes and the efficacy of Sulphonylurea as an anti-diabetic drug. References to relevant research are included.
![[object Object]](/_next/static/media/star-bottom.7253800d.svg)
